EMEA Point-Of-Care Diagnostics Market Size Worth USD 22.66 Billion by 2034 | CAGR: 6.1%

The global EMEA point-of-care diagnostics market size is expected to reach USD 22.66 billion by 2034, according to a new study by Polaris Market Research. The report “EMEA Point-Of-Care Diagnostics Market Share, Size, Trends, Industry Analysis Report: By Product, End Use (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory, and Others), and Region (Europe, and Middle East & Africa); Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Point-of-care (POC) diagnostics refer to rapid medical testing conducted at or near the site of patient care, allowing timely clinical decision-making. A major trend shaping the EMEA point-of-care diagnostics market development is the increasing integration of digital health technologies, such as artificial intelligence (AI) and cloud-based data analytics. These advancements improve diagnostic accuracy, allow real-time monitoring, and facilitate seamless data sharing between patients and healthcare providers. The growing adoption of connected POC devices supports personalized treatment approaches and improves overall healthcare efficiency. The demand for technologically advanced POC solutions is expected to rise as healthcare systems continue to adopt digital transformation.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/emea-point-of-care-diagnostics-market/request-for-sample

Another major trend driving the EMEA point-of-care diagnostics market growth is the shift toward decentralized healthcare, highlighting accessibility and convenience in diagnostic testing. The rising prevalence of chronic and infectious diseases has heightened the need for rapid, on-site testing solutions that reduce dependency on centralized laboratories. POC diagnostics play a critical role in improving early disease detection and patient management, particularly in resource-limited settings. The expansion of home-based and community healthcare models further accelerates the demand for portable and user-friendly diagnostic devices. The adoption of decentralized POC testing is expected to expand, with healthcare providers focusing on improving patient-centric care.

Top of FormEMEA Point-Of-Care Diagnostics Market Report Highlights

• In terms of product, the glucose testing segment led the EMEA point-of-care diagnostics market in 2024, driven by the high prevalence of diabetes and the increasing demand for continuous glucose monitoring solutions.
• Based on end use, the home segment is anticipated to experience the fastest growth during the forecast period, fueled by the rising trend toward decentralized, patient-centric healthcare models.
• Germany dominated the EMEA point-of-care diagnostics market revenue in 2024, supported by its advanced healthcare infrastructure, high healthcare spending, and the strong presence of key industry players.
• The UK is projected to witness the fastest growth in the EMEA point-of-care diagnostics market, driven by increased investments in digital healthcare and a strong focus on decentralized diagnostic solutions.
• A few global key market players include Abbott; BD; BIOMÉRIEUX; Danaher Corporation; F. Hoffmann-La Roche Ltd; Nova Biomedical; QIAGEN; Siemens Healthcare Private Limited; Trividia Health, Inc.; and Werfen.

Polaris Market Research has segmented the EMEA point-of-care diagnostics market report on the basis of product, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020–2034)

• Glucose Testing
• Hb1Ac Testing
• Coagulation Testing
• Fertility/Pregnancy
• Infectious Disease, including HIV POC
• Cancer Makers
• Others

By End Use Outlook (Revenue, USD Billion, 2020–2034)

• Clinics
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory
• Others

By Regional Outlook ((Revenue, USD Billion, 2020–2034)

• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa

EMEA Point-Of-Care Diagnostics Market Report Scope